BioXcel Therapeutics Inc logo

BioXcel Therapeutics Inc

FRA:BX2 (USA)  
€ 2.37 (+1.05%) Apr 30
At Loss
Market Cap:
€ 73.68M ($ 78.64M)
Enterprise V:
€ 107.46M ($ 114.69M)
Volume:
-
Avg Vol (2M):
4.37K
Also Trade In:

BioXcel Therapeutics Inc Valuation Measures